Erysipelas primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Category) |
||
| Line 27: | Line 27: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}}[[Category:Emergency medicine]] | ||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Dermatology]] | |||
Revision as of 01:33, 21 September 2017
|
Erysipelas Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erysipelas primary prevention On the Web |
|
American Roentgen Ray Society Images of Erysipelas primary prevention |
|
Risk calculators and risk factors for Erysipelas primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
The primary prevention of erysipelas involves preventing pathogenesis from streptococcal infection, as well as preventing the original streptococcal infection.
Primary Prevention
The primary prevention of erysipelas involves preventing pathogenesis from streptococcal infection, as well as preventing the original streptococcal infection.[1]
Preventing pathogenesis from streptococcal infection:
- Avoiding cutaneous barrier disruptions, such as cuts, abrasions, or ulcers[2]
- Maintaining a BMI below overweight and obesity through lifestyle factors, including diet and exercise
- Prophylactic administration of penicillin if streptococcal infection is confirmed[3]
Preventing streptoccocal infection
- Avoiding direct contact with infected individuals
- Practicing good hygiene, such as hand-washing
- Avoiding cutaneous disruptions
- Maintaining immunocompetence
References
- ↑ "Group A Strep | Questions and Answers | GAS | CDC".
- ↑ Inghammar M, Rasmussen M, Linder A (2014). "Recurrent erysipelas--risk factors and clinical presentation". BMC Infect. Dis. 14: 270. doi:10.1186/1471-2334-14-270. PMC 4033615. PMID 24884840.
- ↑ Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H (2012). "Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial". Br. J. Dermatol. 166 (1): 169–78. doi:10.1111/j.1365-2133.2011.10586.x. PMC 3494300. PMID 21910701.